There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
EMPAGLIFLOZIN; LINAGLIPTIN (EM pa gli FLOE zin; lin a GLIP tin) treats type 2 diabetes. It works by decreasing your blood sugar (glucose). Changes to diet and exercise are often combined with this medication.
|
EMPAGLIFLOZIN; LINAGLIPTIN (EM pa gli FLOE zin; lin a GLIP tin) treats type 2 diabetes. It works by decreasing your blood sugar (glucose). Changes to diet and exercise are often combined with this medication.
|
|
AMANTADINE (a MAN ta deen) treats the symptoms of Parkinson disease. It works by balancing substances in your brain that help manage body movements and coordination. This reduces the symptoms of Parkinson, such as body stiffness and tremors.
|
AMANTADINE (a MAN ta deen) treats the symptoms of Parkinson disease. It works by balancing substances in your brain that help manage body movements and coordination. This reduces the symptoms of Parkinson, such as body stiffness and tremors.
|
|
VILOBELIMAB (vil oh bel i mab) treats severe COVID-19 in people who are hospitalized. It works by slowing down an overactive immune system, which prevents worsening symptoms. It is a monoclonal antibody. The FDA has allowed the emergency use of this medication.
|
VILOBELIMAB (vil oh bel i mab) treats severe COVID-19 in people who are hospitalized. It works by slowing down an overactive immune system, which prevents worsening symptoms. It is a monoclonal antibody. The FDA has allowed the emergency use of this medication.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|